Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Shire reports pre-dialysis Fosrenol data

Shire (LSE:SHP; SHPGY) said Fosrenol lanthanum carbonate missed the primary endpoint of control

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE